Stocks to buy

SoFi Stock: Will Biden’s Move Lead the Fintech Darling to Rocket?

Student loan refinancing is where SoFi (SOFI) first cut its teeth in the finance industry. Since, it has greatly expanded its horizons, pushing into investing, crypto, checking and savings, credit cards and loan programs. And indeed, that’s why we love the stock so much for the long term.

But at the end of the day, the majority of SoFi’s revenues still come from the company’s student loan refinancing business. And with the moratorium, that business has been put on hold. Well, that student reprieve is reaching its end. And now the Biden administration is set to decide on how to handle student loans going forward. Will it extend the pause, cancel some (or all) debt, or resume payments without cancellations? It’s become a real hot topic.

The data shows that since this payment freeze’s implementation, student debtors have been spending their would-be repayments elsewhere – travel, clothing, restaurants, etc. And it all piles into the inflationary problem. The Biden administration is looking to do everything possible to combat this high inflation. And it will likely resume student loan repayments at the end of this month.

It will have a great deflationary impact on the U.S. economy — and be a massive boon for SoFi stock.

Indeed, this is a company that – even with a pause on student loan debt repayment – is still growing like wildfire. And the restarting of those payments will further accelerate this company’s huge growth narrative into 2023. Paired with disinflation and a dovish pivot from the Fed, this could really lead to an enormous breakout in SoFi stock.

Catch the full episode at Hypergrowth Investing on YouTube!

On the date of publication, Luke Lango did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Articles You May Like

BlackRock expands its tokenized money market fund to Polygon and other blockchains
5 Stocks to Buy on a Trump Victory 
Gary Gensler reviews his accomplishments, says he was ‘proud to serve’ as SEC chair
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
Greenlight’s David Einhorn says the markets are broken and getting worse